• Agosto 16, 2022

Luglio 2022. Rilasciati i nuovi documenti Pfizer

Il nuovo lotto di documenti sui vaccini Pfizer della FDA è stato prodotto (90.877 pagine), ed è disponibile presso Public Health and Medical Professionals for Transparency.

 Link ai nuovi documenti (pagine 1 e 2 su PHMPT):

Pag. 1
FDA-CBER-2021-5683-0296904 to -0307543_125742_S1_M5_c4591001-S-D-suppce.zip (xpt)
FDA-CBER-2021-5683-0286267 to -0296903_125742_S1_M5_c4591001-S-Supp-D-suppce.zip (xpt)
FDA-CBER-2021-5683-0286072 to -0286266_125742_S1_M5_c4591001-S-Supp-D-relrec.zip (xpt)
FDA-CBER-2021-5683-0285652 to -0286071_125742_S1_M5_c4591001-S-D-pe.zip (xpt)
FDA-CBER-2021-5683-0285644 to -0285651_125742_S1_M5_c4591001-S-D-mo.zip (xpt)
FDA-CBER-2021-5683-0282366 to -0285643_125742_S1_M5_c4591001-S-D-mb.zip (xpt)
FDA-CBER-2021-5683-0282329 to -0282365_125742_S1_M5_c4591001-S-D-ie.zip (xpt)
FDA-CBER-2021-5683-0282130 to -0282328_125742_S1_M5_c4591001-S-D-cm.zip (xpt)
FDA-CBER-2021-5683-0225598 to -0282129_125742_S1_M5_c4591001-A-Supp-D-adfacevd.zip (xpt)
FDA-CBER-2021-5683-0225100 to -0225597_125742_S1_M5_c4591001-A-D-adcm.zip (xpt)
125742_S2_M1_comvlabp vial puurs.pdf
125742_S2_M1_com195lpus carton puurs.pdf
125742_S2_M1_comvlabkz vial kzoo.pdf  
125742_S2_M1_com25ctpus carton puurs.pdf
125742_S2_M1_com195lkz carton kzoo.pdf
125742_S2_M1_com25ctkz carton kzoo.pdf
125742_S1_M5_5351_c4591001 interim mth6 sap.pdf
125742_S1_M5_5351_c4591001 interim mth6 protocol deviations.pdf
125742_S1_M5_5351_c4591001 interim mth6 lab measurements sensitive.pdf
125742_S1_M5_5351_c4591001 interim mth6 excluded patients sensitive.pdf
125742_S1_M5_5351_c4591001 interim mth6 excluded patients.pdf
125742_S1_M5_5351_c4591001 interim mth6 errata.pdf
125742_S1_M5_5351_c4591001 interim mth6 efficacy response.pdf
125742_S1_M5_5351_c4591001 interim mth6 discontinued patients.pdf
125742_S1_M5_5351_c4591001 fa interim sap.pdf

Pag. 2
125742_S1_M5_5351_c4591001 interim mth6 compliance sensitive.pdf
125742_S2_M1_right of reference.pdf
125742_S2_M1_loa dmf 031786 vials.pdf
125742_S2_M1_loa dmf 012683 vials.pdf
125742_S2_M1_loa dmf 011820 vials.pdf
125742_S2_M1_loa dmf 011793 vials.pdf
125742_S2_M1_loa dmf 011321 vials.pdf
125742_S2_M1_hospira diluent label.pdf
125742_S2_M1_loa dmf 10953 stopper.pdf
125742_S2_M1_hospira diluent carton.pdf
125742_S2_M1_fk diluent stamp.pdf
125742_S2_M1_fk diluent carton.pdf
125742_S2_M5_5354_wi235284-protocol.pdf
125742_S1_M5_5351_c4591001-interim-mth6-interlab-standard.pdf
125742_S1_M5_5351_c4591001-fa-interim-narrative-sensitive.pdf
125742_S1_M5_5351_c4591001-interim-mth6-adverse-events.zip (pdf)

eVenti Avversi

Read Previous

Malore improvviso: muore storica volontaria Croce Rossa, categoria soggetta a OBBLIGO VACCINALE

Read Next

Studio trova la “correlazione” tra un maggiore utilizzo della mascherina e decessi per COVID-19